CAMBRIDGE, Mass., April 30, 2025--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its ...
BOSTON--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced it has raised an oversubscribed $5.2 million seed ...
CAMBRIDGE, Mass., October 01, 2025--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback